@engadget.com 3 years ago
23andMe is going public as it pushes further into healthcare
@xconomy.com 4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com 4 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak